NCT07281391Recruiting
IOP Reduction in Pigmentary Glaucoma Using DSLT
Mann Eye Institute
Start Date
3/19/2026
Completion Date
4/1/2027
Summary
This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
Eligibility Criteria
Age Range: No minimum to No maximum
Inclusion Criteria:
* Adult patients with pigmentary dispersion syndrome with elevated IOP or mild to moderate (based on AAO Preferred Practice Program criteria) pigmentary glaucoma with glaucomatous optic neuropathy and corresponding visual field/RNFL loss.
* Treatment naive, or washed out IOP ranging from ≥18-34 mmHg
* Central corneal thickness (CCT) 480-600 µm
* Able to complete medication washout and follow-up
Exclusion Criteria:
* Prior incisional glaucoma surgery or glaucoma-related procedures in the study eye
* Prior laser trabeculoplasty \<3 years
* Prior intraocular surgery and refractive surgery, except for cataract surgery unless greater than 2 years
* Patients anticipating cataract surgery within the follow-up period
* History of ocular inflammation and infection
* All other secondary glaucoma including exfoliative
* Patients unable to have DSLT treatment
Interventions
DEVICE
Voyager DSLT
Conditions
Pigmentary Dispersion SyndromePigmentary Dispersion Glaucoma
Locations
Mann Eye Institute
Houston, Texas 76134-2099
United States